These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

193 related articles for article (PubMed ID: 27172716)

  • 1. [HOMOCYSTEINE AS A PROGNOSTIC MARKER OF ATRIAL REMODELING AND CLINICAL PICTURE IN PATIENTS WITH PAROXYSMAL AND PERSISTENT FORMS OF ATRIAL FIBRILLATION].
    Snezhitsky VA; Yatskevich ES; Doroshenko EM; Smirnov VY; Dolgoshey TS; Rubinsky AY
    Klin Med (Mosk); 2016; 94(1):16-22. PubMed ID: 27172716
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Circulating homocysteine levels in patients with radiofrequency catheter ablation for atrial fibrillation.
    Shimano M; Inden Y; Tsuji Y; Kamiya H; Uchikawa T; Shibata R; Murohara T
    Europace; 2008 Aug; 10(8):961-6. PubMed ID: 18550508
    [TBL] [Abstract][Full Text] [Related]  

  • 3. MMP-9 in atrial remodeling in patients with atrial fibrillation.
    Lewkowicz J; Knapp M; Tankiewicz-Kwedlo A; Sawicki R; Kamińska M; Waszkiewicz E; Musiał WJ
    Ann Cardiol Angeiol (Paris); 2015 Sep; 64(4):285-91. PubMed ID: 25869465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Electroanatomic remodeling of the left atrium in paroxysmal and persistent atrial fibrillation patients without structural heart disease.
    Teh AW; Kistler PM; Lee G; Medi C; Heck PM; Spence SJ; Sparks PB; Morton JB; Kalman JM
    J Cardiovasc Electrophysiol; 2012 Mar; 23(3):232-8. PubMed ID: 21955090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Five-year follow-up after catheter ablation of persistent atrial fibrillation using the stepwise approach and prognostic factors for success.
    Schreiber D; Rostock T; Fröhlich M; Sultan A; Servatius H; Hoffmann BA; Lüker J; Berner I; Schäffer B; Wegscheider K; Lezius S; Willems S; Steven D
    Circ Arrhythm Electrophysiol; 2015 Apr; 8(2):308-17. PubMed ID: 25744570
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Progression of paroxysmal atrial fibrillation to persistent atrial fibrillation in patients with bradyarrhythmias.
    Saksena S; Hettrick DA; Koehler JL; Grammatico A; Padeletti L
    Am Heart J; 2007 Nov; 154(5):884-92. PubMed ID: 17967594
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The role of an electropharmacological transesophageal test in the prevention of paroxysmal atrial fibrillation. Experience with flecainide].
    De Sisti A; Matteucci C; Patrissi T; Accogli S; Di Lorenzo M; Sasdelli M; Ciolli A; Lo Sardo G; Palamara A
    G Ital Cardiol; 1998 Dec; 28(12):1391-9. PubMed ID: 9887393
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Catheter ablation of atrial fibrillation in patients with hypertrophic cardiomyopathy: atrial fibrillation type determines the success rate.
    Derejko P; Polańska M; Chojnowska L; Michałowska I; Wójcik A; Piotrowicz E; Lech A; Kłopotowski M; Baranowski R; Przybylski A; Bilińska M; Sierpiński R; Walczak F; Szumowski L
    Kardiol Pol; 2013; 71(1):17-24. PubMed ID: 23348529
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Serum Soluble Semaphorin 4D is Associated with Left Atrial Diameter in Patients with Atrial Fibrillation.
    Xiang L; You T; Chen J; Xu W; Jiao Y
    Med Sci Monit; 2015 Sep; 21():2912-7. PubMed ID: 26417899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased plasma homocysteine predicts arrhythmia recurrence after minimally invasive epicardial ablation for nonvalvular atrial fibrillation.
    Nasso G; Bonifazi R; Romano V; Brigiani MS; Fiore F; Bartolomucci F; Lamarra M; Fattouch K; Rosano G; Gaudino M; Spirito R; Gaudio C; Speziale G
    J Thorac Cardiovasc Surg; 2013 Oct; 146(4):848-53. PubMed ID: 22944088
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Increased expression of NF-AT3 and NF-AT4 in the atria correlates with procollagen I carboxyl terminal peptide and TGF-β1 levels in serum of patients with atrial fibrillation.
    Zhao F; Zhang S; Chen Y; Gu W; Ni B; Shao Y; Wu Y; Qin J
    BMC Cardiovasc Disord; 2014 Nov; 14():167. PubMed ID: 25422138
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evaluation of factors affecting persistence of atrial fibrillation in patients with concomitant atrial flutter treated with percutaneous radiofrequency current ablation of the right atrial cavotricuspid isthmus.
    Chodór P; Białkowska B; Hapeta B; Bugała K; Kłyś J; Pruszkowska-Skrzep P; Sredniawa B; Kalarus Z
    Kardiol Pol; 2013; 71(3):247-52. PubMed ID: 23575779
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Patients originally diagnosed with idiopathic atrial fibrillation more often suffer from insidious coronary artery disease compared to healthy sinus rhythm controls.
    Weijs B; Pisters R; Haest RJ; Kragten JA; Joosen IA; Versteylen M; Timmermans CC; Pison L; Blaauw Y; Hofstra L; Nieuwlaat R; Wildberger J; Crijns HJ
    Heart Rhythm; 2012 Dec; 9(12):1923-9. PubMed ID: 22885921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Natriuretic peptides in patients with atrial fibrillation.
    Wozakowska-Kapłon B; Opolski G; Herman Z; Kosior D
    Cardiol J; 2008; 15(6):525-9. PubMed ID: 19039756
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The Association of Serum Galectin-3 Levels with Atrial Electrical and Structural Remodeling.
    Yalcin MU; Gurses KM; Kocyigit D; Canpinar H; Canpolat U; Evranos B; Yorgun H; Sahiner ML; Kaya EB; Hazirolan T; Tokgozoglu L; Oto MA; Ozer N; Guc D; Aytemir K
    J Cardiovasc Electrophysiol; 2015 Jun; 26(6):635-40. PubMed ID: 25684038
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Progression of atrial fibrillation in the REgistry on Cardiac rhythm disORDers assessing the control of Atrial Fibrillation cohort: clinical correlates and the effect of rhythm-control therapy.
    De Vos CB; Breithardt G; Camm AJ; Dorian P; Kowey PR; Le Heuzey JY; Naditch-Brûlé L; Prystowsky EN; Schwartz PJ; Torp-Pedersen C; Weintraub WS; Crijns HJ
    Am Heart J; 2012 May; 163(5):887-93. PubMed ID: 22607868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. High concentrations of B-type natriuretic peptide and left ventricular diastolic dysfunction in patients with paroxysmal/persistent atrial fibrillation as possible markers of conversion into permanent form of arrhythmia: 1-year prospective evaluation.
    Dabrowski R; Borowiec A; Janas J; Firek B; Kowalik I; Smolis-Bak E; Luczak D; Sosnowski C; Kazimierska B; Szwed H
    Kardiol Pol; 2010 Aug; 68(8):893-900. PubMed ID: 20730719
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Human atrial fibrillation substrate: towards a specific fibrotic atrial cardiomyopathy.
    Kottkamp H
    Eur Heart J; 2013 Sep; 34(35):2731-8. PubMed ID: 23761394
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical correlates of immediate success and outcome at 1-year follow-up of real-world cardioversion of atrial fibrillation: the Euro Heart Survey.
    Pisters R; Nieuwlaat R; Prins MH; Le Heuzey JY; Maggioni AP; Camm AJ; Crijns HJ;
    Europace; 2012 May; 14(5):666-74. PubMed ID: 22223715
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early management of atrial fibrillation to prevent cardiovascular complications.
    Nattel S; Guasch E; Savelieva I; Cosio FG; Valverde I; Halperin JL; Conroy JM; Al-Khatib SM; Hess PL; Kirchhof P; De Bono J; Lip GY; Banerjee A; Ruskin J; Blendea D; Camm AJ
    Eur Heart J; 2014 Jun; 35(22):1448-56. PubMed ID: 24536084
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.